Section 460.1 - Drug Utilization Review Board(a) The Drug Utilization Review Board shall be established by the department consistent with section 1927(g)(3) of the Social Security Act ( 42 U.S.C. § 1396r - 8(g)(3) ). The board shall have the following powers and duties: (1) To advise the department and the secretary on the drug utilization review controls for prescription drugs as required by section 1927(g)(3) of the Social Security Act, including appropriate utilization protocols for individual medications and for therapeutic categories and prior authorization guidelines.(2) To serve in an advisory capacity to the secretary for the purpose of developing and maintaining drug utilization review controls for prescription drugs and serve to promote patient safety by an increased review and awareness of outpatient prescribed drugs in the department's medical assistance program.(b) The board shall publicize its meetings pursuant to 65 Pa.C.S. Ch. 7 (relating to open meetings). The committee's deliberations, recommendations and decisions shall be open to the public, except as limited by 65 Pa.C.S. §§ 707 (relating to exceptions to open meetings) and 708 (relating to executive sessions).1967, June 13, P.L. 31, No. 21, art. 4, § 460.1, added 2008, July 4, P.L. 557, No. 44, §4, effective in 60 days [ 9/2/2008].